Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,724.00
Bid: 2,722.00
Ask: 2,724.00
Change: -18.00 (-0.66%)
Spread: 2.00 (0.073%)
Open: 2,746.00
High: 2,754.00
Low: 2,714.00
Prev. Close: 2,742.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

25 Apr 2019 07:00

RNS Number : 0140X
Coca-Cola HBC AG
24 April 2019
 

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Publication of Base Prospectus

 

 

Zug, Switzerland - 24 April 2019 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces that the base prospectus dated 24 April 2019, in respect of the update of the €3,000,000,000 Euro Medium-Term Note Programme and its increase to a €5,000,000,000 Euro Medium-Term Note Programme, by Coca-Cola HBC Finance B.V. as issuer and guaranteed by Coca-Cola HBC (the "Base Prospectus"), originally established on 3 June 2013, has been approved by the UK Listing Authority.

 

To view the Base Prospectus, please paste the following URL into the address bar of your browser.

 

http://www.coca-colahellenic.com/investorrelations/Debtholders/Fundingsources/ 

 

The Base Prospectus has also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

 

 

Enquiries

Coca‑Cola HBC Group

 

 

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

 

 

Vasso Aliferi

Investor Relations Manager

Tel: +41 44 835 9274

 vasso.aliferi@cchellenic.com

 

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with an annual sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC has been listed in the Dow Jones Sustainability Indices since 2008, and ranked among the top beverage companies in the Global and European indices for the past five years. Coca-Cola HBC is also included in the FTSE4Good Index, rated "AAA" on the MSCI ESG index, rated "A" for Climate and Water by CDP and listed on the Sustainalytics and Vigeo rankings.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PDISEAFWLFUSEIL
Date   Source Headline
26th Jun 20245:27 pmRNSTransaction in Own Shares
25th Jun 20245:17 pmRNSTransaction in Own Shares
24th Jun 20245:18 pmRNSTransaction in Own Shares
21st Jun 20245:11 pmRNSTransaction in Own Shares
20th Jun 20245:45 pmRNSTransaction in Own Shares
19th Jun 20245:14 pmRNSTransaction in Own Shares
18th Jun 20245:09 pmRNSTransaction in Own Shares
18th Jun 20244:23 pmRNSDirector/PDMR Shareholding
17th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 20245:11 pmRNSTransaction in Own Shares
14th Jun 20247:09 amRNSTransaction in Own Shares
11th Jun 20245:41 pmRNSTransaction in Own Shares
10th Jun 20245:25 pmRNSTransaction in Own Shares
5th Jun 20245:32 pmRNSTransaction in Own Shares
4th Jun 20245:28 pmRNSTransaction in Own Shares
3rd Jun 20245:19 pmRNSTransaction in Own Shares
3rd Jun 20244:11 pmRNSIssue of Equity and total voting rights
31st May 20245:25 pmRNSTransaction in Own Shares
30th May 20245:36 pmRNSTransaction in Own Shares
29th May 20243:25 pmRNSDirector/PDMR Shareholding
29th May 20243:19 pmRNSDirector/PDMR Shareholding
28th May 202410:07 amRNSDirector/PDMR Shareholding
28th May 202410:04 amRNSDirector/PDMR Shareholding
22nd May 20245:43 pmRNSDirector/PDMR Shareholding
21st May 20246:01 pmRNSComposition of the Board Committees
21st May 20245:55 pmRNSResult of AGM
20th May 20244:44 pmRNSDirector/PDMR Shareholding
15th May 20244:19 pmRNSDirector/PDMR Shareholding
13th May 202411:30 amRNSDirector/PDMR Shareholding
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.